Three developments are converging to make 2026 a pivotal year for dermatology compounding: the FDAs peptide reclassification is restoring access to key molecules used in skin and wound healing, tightening quality standards are separating accredited pharmacies from the rest, and digital prescribing platforms are finally eliminating the operational friction that has kept many dermatologists from incorporating compounding into their standard workflow
Dalbir Singh reposted thisZapata AI Zapata AI 2yDalbir Singh reposted thisLive from Times Square with Christopher Savoie: ZPTA is now trading on the Nasdaq Stock Exchange
ensure adequate iron, folate, vitamin D, zinc, magnesium, and iodine
Offering their own twist on the currently trending at-home microneedling technology, GENABELLEs Vita Glow Spicule Shot contains 1,000ppm high-purity microspicules made from Hydrolysed Sponge
What were doing in my lab, and the others around the world, is trying to compress the period of our lives that is morbid
DOI: 10.1016/S1474-4422(06)70628-7 17
